Zhichao Zhou 周稚超 (Zhichao Zhou)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

Purinergic signalling

American journal of physiology. Heart and circulatory physiology

The Journal of physiology

Basic research in cardiology

Erasmus MC (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Erasmus MC Sep 01 2009 - Nov 12 2013

Netherlands

PHD :: Cardiology

Publications

Alessia Bibi, Monika Bartekova, Shrey Gandhi, Simona Greco, Alisia Madè, Moumita Sarkar, Victoria Stopa, Spyros Tastsoglou, David de Gonzalo-Calvo, Yvan Devaux, Costanza Emanueli, Artemis G Hatzigeorgiou, Anne Yaël Nossent, Zhichao Zhou 周稚超, Fabio Martelli, null null
Circular RNA regulatory role in pathological cardiac remodelling. British journal of pharmacology (2024)
Ximeng He, Zhichao Zhou 周稚超
Purinergic P2X 3 receptors in the carotid body as new therapeutic targets for controlling heart failure. Purinergic signalling (2023)
Eftychia Kontidou, Aida Collado, John Pernow, Zhichao Zhou 周稚超
Erythrocyte-Derived microRNAs: Emerging Players in Cardiovascular and Metabolic Disease. Arteriosclerosis, thrombosis, and vascular biology (2023)
Xin Cao, Zhichao Zhou 周稚超
Purinergic activation in response to hemodynamic force directs heart valve development. Purinergic signalling 18 (2) (2022)
Aida Collado, Lu Gan, John Tengbom, Eftychia Kontidou, John Pernow, Zhichao Zhou 周稚超
Extracellular vesicles and their non-coding RNA cargos: Emerging players in cardiovascular disease. The Journal of physiology (2022)
Ying Zhang, Bernhard Wernly, Xin Cao, S Jamal Mustafa, Yong Tang, Zhichao Zhou 周稚超
Adenosine and adenosine receptor-mediated action in coronary microcirculation. Basic research in cardiology 116 (1) (2021)
Zhichao Zhou 周稚超
Purinergic interplay between erythrocytes and platelets in diabetes-associated vascular dysfunction. Purinergic signalling (2021)
Bernhard Wernly, Zhichao Zhou 周稚超
More purinergic receptors deserve attention as therapeutic targets for the treatment of cardiovascular disease. American journal of physiology. Heart and circulatory physiology 319 (4) (2020)
Bernhard Wernly, David Erlinge, John Pernow, Zhichao Zhou 周稚超
Ticagrelor: a cardiometabolic drug targeting erythrocyte-mediated purinergic signaling? American journal of physiology. Heart and circulatory physiology 320 (1) (2020)
Ali Mahdi, John Tengbom, Michael Alvarsson, Bernhard Wernly, Zhichao Zhou 周稚超, John Pernow
Red Blood Cell Peroxynitrite Causes Endothelial Dysfunction in Type 2 Diabetes Mellitus via Arginase. Cells 9 (7) (2020)
Ali Mahdi, Tong Jiao, Yahor Tratsiakovich, Jiangning Yang, Claes-Göran Östenson, John Pernow, Zhichao Zhou 周稚超
Altered Purinergic Receptor Sensitivity in Type 2 Diabetes-Associated Endothelial Dysfunction and Up₄A-Mediated Vascular Contraction. International journal of molecular sciences 19 (12) (2018)
Bunyen Teng, Hicham Labazi, Changyan Sun, Yan Yang, Xiaorong Zeng, S Jamal Mustafa, Zhichao Zhou 周稚超
Divergent coronary flow responses to uridine adenosine tetraphosphate in atherosclerotic ApoE knockout mice. Purinergic signalling 13 (4) (2017)

Zhichao Zhou 周稚超.css-eqlu8i{font-size:small;padding-left:4px;} (Zhichao Zhou)

Publication Activity (10 Years)

Top Topics

Top Venues

Zhichao Zhou 周稚超 (Zhichao Zhou)